Cargando…

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series

Prolonged SARS-CoV-2 infections are widely described in immunosuppressed patients, but safe and effective treatment strategies are lacking. We aimed to outline our approach to treating persistent COVID-19 in patients with immunosuppression from different causes. In this case series, we retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longo, Bianca Maria, Venuti, Francesco, Gaviraghi, Alberto, Lupia, Tommaso, Ranzani, Fabio Antonino, Pepe, Andrea, Ponzetta, Laura, Vita, Davide, Allice, Tiziano, Gregorc, Vanesa, Frascione, Pio Manlio Mirko, De Rosa, Francesco Giuseppe, Calcagno, Andrea, Bonora, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525462/ https://www.ncbi.nlm.nih.gov/pubmed/37760757 http://dx.doi.org/10.3390/antibiotics12091460

Ejemplares similares

Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature
por: Lupia, Tommaso, et al.
Publicado: (2023)

Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting
por: Venuti, Francesco, et al.
Publicado: (2023)

Co-infection with other respiratory pathogens in COVID-19 patients
por: Calcagno, Andrea, et al.
Publicado: (2021)

Antibody Therapies for Large B-Cell Lymphoma
por: Novo, Mattia, et al.
Publicado: (2021)

On the SARS-CoV-2 “Variolation Hypothesis”: No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin Lymphoma
por: Lupia, Tommaso, et al.
Publicado: (2023)

Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients
por: Trunfio, Mattia, et al.
Publicado: (2021)

Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020)

Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm?
por: Mornese Pinna, Simone, et al.
Publicado: (2021)

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
por: Trunfio, Mattia, et al.
Publicado: (2022)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
por: Ruggiero, Tina, et al.
Publicado: (2013)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman
por: Di Girolamo, L., et al.
Publicado: (2023)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
por: Ferreira, Victor H., et al.
Publicado: (2022)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic
por: Burdino, Elisa, et al.
Publicado: (2022)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

The unmet need for COVID-19 treatment in immunocompromised patients
por: Alessandra, D’Abramo, et al.
Publicado: (2022)

Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts
por: Nevejan, Louis, et al.
Publicado: (2022)

Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient
por: Alisoltani, Arghavan, et al.
Publicado: (2023)

Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend
por: Stroffolini, Giacomo, et al.
Publicado: (2021)

Natural killer cells and unconventional T cells in COVID-19
por: Björkström, Niklas K, et al.
Publicado: (2021)

Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2
por: Cerutti, Francesco, et al.
Publicado: (2020)

Correction: The unmet need for COVID-19 treatment in immunocompromised patients
por: D’Abramo, Alessandra, et al.
Publicado: (2023)

IgE and macrophages for cancer rescue?
por: Conti, Pio, et al.
Publicado: (2019)

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022)

480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
por: KAMEGAI, K O H E I, et al.
Publicado: (2023)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
por: Malahe, S Reshwan K, et al.
Publicado: (2022)

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients
por: Gliga, Smaranda, et al.
Publicado: (2022)

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023)

Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options
por: Trunfio, Mattia, et al.
Publicado: (2022)

A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold
por: Lupia, Tommaso, et al.
Publicado: (2022)

Omicron variant evolution on vaccines and monoclonal antibodies
por: Sabbatucci, Michela, et al.
Publicado: (2023)

Exuberant oral lesions in an immunocompromised patient
por: Garbelini Lima Forneck, Cleide, et al.
Publicado: (2020)

Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
por: Carnevale-Schianca, Fabrizio, et al.
Publicado: (2021)

Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
por: Huygens, Sammy, et al.
Publicado: (2022)

Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis
por: Ordaya, Eloy E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2rruga8lg7qia0qsppuh9utjnc